Harcharan Gill

Back to Profile

Publication Details

  • Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy.

    King CR, Presti JC, Brooks JD, Gill H, Spiotto MT. Int J Radiat Oncol Biol Phys. 2008; 70 (5): 1472-7

    Identification of patients most likely to benefit from salvage radiotherapy (RT) using postoperative (postop) prostate-specific antigen (PSA) kinetics.

    PubMedID: 17935902

Stanford Medicine Resources:

Footer Links: